| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.069 | 0.7 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.073 | 0.7 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |